SG Americas Securities’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.26M | Buy |
|
|||||
|
2025
Q2 | $362K | Sell |
|
|||||
|
2025
Q1 | $295K | Sell |
|
|||||
|
2024
Q4 | $523K | Buy |
|
|||||
|
2024
Q3 | $496K | Buy |
|
|||||
|
2024
Q2 | $139K | Buy |
|
|||||
|
2024
Q1 | $160K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $390K | Sell |
|
|||||
|
2023
Q1 | $752K | Buy |
|
|||||
|
2022
Q4 | $696K | Buy |
|
|||||
|
2022
Q3 | $609K | Buy |
|
|||||
|
2022
Q2 | $363K | Sell |
|
|||||
|
2022
Q1 | $1.59M | Sell |
|
|||||
|
2021
Q4 | $3.77M | Buy |
|
|||||
|
2021
Q3 | $1.95M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Sell |
|
|||||
|
2021
Q1 | $906K | Buy |
|
|||||
|
2020
Q4 | $334K | Sell |
|
|||||
|
2020
Q3 | $787K | Buy |
|
|||||
|
2020
Q2 | $724K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $112K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $906K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $253K | Buy |
|
|||||
|
2017
Q2 | $101K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $482K | Buy |
|
|||||
|
2016
Q3 | $456K | Buy |
|
|||||
|
2016
Q2 | $374K | Buy |
|